HP Ellis, M Greenslade, B Powell, I Spiteri… - Frontiers in …, 2015 - frontiersin.org
Glioblastoma (GB) is the most common primary malignant brain tumor, and despite the availability of chemotherapy and radiotherapy to combat the disease, overall survival …
In silico models and computer simulation are invaluable tools to better understand complex biological processes such as cancer evolution. However, the complexity of the biological …
N Bayat, R Izadpanah… - Asian Pacific journal …, 2018 - ncbi.nlm.nih.gov
Purpose: Glioblastoma multiform (GBM) is the most aggressive glial neoplasm. Researchers have exploited the fact that GBMs are highly vascularized tumors. Anti-angiogenic strategies …
In this article, we propose a proof of concept for the automatic planning of personalized radiotherapy for brain tumors. A computational model of glioblastoma growth is combined …
X He, Z Liu, Y Peng, C Yu - Biochemical and biophysical research …, 2016 - Elsevier
MicroRNAs (miRNAs) are small non-coding RNAs frequently dysregulated in human malignancies. In this study, we found that miR-181c was down-regulated both in …
L Kong, J Gao, J Hu, R Lu, J Yang, X Qiu, W Hu… - Cancer …, 2019 - Springer
Background Glioblastoma (GBM) is a highly virulent tumor of the central nervous system, with a median survival< 15 months. Clearly, an improvement in treatment outcomes is …
Brain metastases (BMs) are the most common intracranial tumor type and a significant health concern, affecting approximately 10% to 30% of all oncological patients. Although …
E Heynold, M Zimmermann, N Hore… - Molecular Imaging and …, 2021 - Springer
Purpose Glioblastomas (GB) and solitary brain metastases (BM) are the most common brain tumors in adults. GB and BM may appear similar in conventional magnetic resonance …
Background In this exploratory analysis of AVAglio, a randomized phase III clinical study that investigated the addition of bevacizumab (Bev) to radiotherapy/temozolomide in newly …